Eu-PIC
Personalized drug therapy
Personalized drug therapy
Integrating Pharmacogenetic information
in existing health care
Coming Up
Upcoming Events
7th ESPT International Congress
Copenhagen
October 25th-27th, 2023
ESPT, European Society of Pharmacogenomics and Personalised Therapy, organises its Annual Congress every 2 years.
European Pharmacogenetics Implementation Consortium
Join us
PURPOSE Eu-PIC
Implementing and supporting Pharmacogenetics for the most important and actionable pharmacogenetic markers into clinical care and monitor uptake and experiences.
Associated Partners
• IFCC: International Federation for Clinical Chemistry
www.ifcc.org.
• ESPT: European Society for Pharmacogenomics and Personal Therapy
www.esptnet.eu
Join Eu-PIC
Do you want do join the European Pharmacogenetics Implementation Consortium?
You can be an active participant from an organization or be a private partner. Please fill in the contactform at the contactpage.
Participating countries Eu-PIC
• Austria • Belgium • Denmark
• Finland • France • Germany
• Greece • Hungary • Italy
• Poland • Portugal • Slovenia
• Spain • Sweden • Switserland
• The Netherlands • Turkey • UK
Focus Eu-PIC
To perform research in, and driving clinical implementation of Pharmacogenetics, as an important tool to improve drug therapy and current health care.
Personalised medicine
Personalised medicine has the potential to respond to, amongst others, the increasing burden of chronic disease and the complexity of co-morbidities and in doing so contribute to the sustainability of health and care systems.
Metabolism by Cytochrome P450
This tutorial discusses how drugs are metabolized by Cytochrome P450 enzymes.
Antidepressants and metabolism
An (extremely) fast or slow metabolism is in many cases caused by variations in CYP2D6 and CYP2C19 enzyme activity. Variations in the genes encoding these enzymes can result in increased or decreased enzyme activity.
QUICK FAQ
How do I participate with Eu-PIC?
Do you want to join the European Pharmacogenetics Implementation Consortium? You can be an active participant from an organization or be a private partner. Please fill in the contactform here.
What is the Mission of Eu-PIC?
Ours mission is to improve patient care in Europe by integrating Pharmacogenetic information in existing health care, personalising drug therapy.
What is the focus of EU-Pic?
Ours focus is to perform research in, and driving clinical implementation of Pharmacogenetics, as an important tool to improve drug therapy and current health care.
Effects of slow metabolism
Patients with a slow metabolism often experience side effects, regardless of what medicine they are prescribed. In addition to side effects, they can also experience toxicity from the medicine used, which poses health risks.
Effects of rapid metabolism
Patients with a rapid metabolism may be unjustifiably accused of being unfaithful to therapy. They may not experience effects of the drug.
Biochemical pathways
Pharmacogenetics is based on the understanding that all drugs are taken through several biochemical pathways to break them down after they are administered. The body needs to eliminate these drugs and does it by breaking them down through biochemical pathways.
WHERE TO FIND US
Address
’s Gravendijkwal 230
3015 CE Rotterdam
Contactperson
Prof. Dr. R.H.N. van Schaik | Dept. Clinical Chemistry, Erasmus MC Rotterdam
PHARMACOGENETICS
Our purpose
Implementing and supporting Pharmacogenetics for the most important and actionable pharmacogenetic markers into clinical care and monitor uptake and experiences.
PERSONALISED MEDICINE
Personalised medicine has the potential to respond to, amongst others, the increasing burden of chronic disease and the complexity of co-morbidities and in doing so contribute to the sustainability of health and care systems.